1. Pharma Delays European Drug Launches Amid U.S. Pricing Pressure and Trump Policy Shifts
Major pharmaceutical companies are delaying the launch of new medicines in Europe, a strategic shift driven by intensifying pressure from the United States market. According to a Reuters report, the industry is grappling with the White House's push to lower prescription drug costs and policy shifts from the Trump admin...